Home › Retinal Degeneration › NCT05355415
Adaptive Optics Imaging of Outer Retinal Diseases
RecruitingObservational study
Who can join
Ages 21 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Are 21 years of age or older, 2. Have the ability to cooperate with instructions during adaptive optics imaging (similar to instructions given during a clinical eye exam), 3. Have the ability to understand and sign an informed consent. (Non-English speaking participants will not be enrolled into the study), and 4. Have been diagnosed with outer retinal disease or condition (Cohort 2). Exclusion Criteria: 1. Have a condition which prevents adequate images from being obtained (e.g. unstable fixation or media opacity), 2. Have visual correction outside of the range +4 diopters (D) to -8 D, 3. Have a history of adverse reaction to mydriatic drops, 4. Have a predisposition to (i.e., narrow iridocorneal angle) or any history of acute angle closure glaucoma (AACG), or 5. Are working under the direct supervision of Drs. Hammer, Cukras and Liu, or any of the NIH/NEI AIs.
About the study
The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnostic methods, biomarkers, and clinical endpoints.
What is being tested
- Adaptive optics imaging (device)
Sponsor: Food and Drug Administration (FDA) · Participants: 100 · Started: Aug 27, 2021
Contact the study team
- Daniel X Hammer, Ph.D. · Phone: 301-796-9320
- Zhuolin Liu, Ph.D. · Phone: 301-796-7914
Official record on ClinicalTrials.gov — NCT05355415
Locations in the U.S.
| Maryland | NIH Clinical Center, Bethesda Food and Drug Administration, Silver Spring |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.